By the background of multinational pharmaceutical companies entered a subtle period in the context of China's new medical reform。How to make more drugs enter the basic drug directory，How to open the regional market，How to integrate government relations，All have become necessary topics。According to the "China Business Daily" report，Novartis China is considering abandoning the centralization system，Implementing branch system，In the past，Novartis China has set up offices in some provinces and cities in China。In the basic drug directory released in August 2009，There are almost no original foreign research medicines，But there is no clear limit on the number of supplements in various provinces，outside stake online sports bettingthe 307 basic drug directory，My stake betting appMost provinces have supplementary plans，For the number of replenishment and supplement varieties, it is the local government，So，Local governments have become a breakthrough for foreign pharmaceutical companies。Novartis related persons are unwilling to disclose more details on the reform of the company's mechanism。Current，There are multiple choices in front of them，Push the new product，Existing product price reduction，Or enter the medical insurance directory through the high -priced drug and medical insurance negotiation mechanism。Merhado's Shuzhi's (Sippedtin) reduced price 50%，Its price is even lower than domestic pharmaceutical companies。Become the only foreign -funded medicine for entering the basic drug directory。My stake betting appIn addition to actively lowering stake sports betting appthe price and lowering price，Another choice of foreign pharmaceutical companies is to negotiate with the medical insurance department。To cope with cancer and other difficult and severe illness，The Ministry of Human Resources and Social Security has also begun to consider introducing some high -priced and high -end drugs in the medical insurance directory。